Christina Chung-lun Wang MD, FRACP, FRCP

Dr. Wang is an investigator at Lundquist Institute and, She is a Professor of Medicine and Assistant Dean in Clinical and Translational Sciences at the David Geffen School of Medicine at UCLA. She is the Associate Director of the UCLA Clinical and Translational Science Institute, and a faculty member of the Division of Endocrinology, Department of Medicine, Harbor-UCLA Medical Center, and Los Angeles Biomedical Research Institute (Harbor-UCLA/LA BioMed), Torrance, California. She was a former Professor of Medicine at the University of Hong Kong. She is an internationally renowned andrologist/endocrinologist and a clinical and basic investigator/educator.

Dr. Wang is an internationally recognized investigator in male reproductive medicine and biology, leading the efforts to develop a safe, effective, and reversible hormonal male contraceptive and optimal methods of male hormone replacement therapy and new androgen replacement for hypogonadal men. Her lab studies the mechanisms and signal pathways of germ cell apoptosis, the hormonal regulation of spermatogenesis, reproductive toxicology, animal models for Klinefelters’ syndrome, hormonal measurements, and semen analysis methods. Additionally, her lab is currently focused on the cytoprotective action of the peptide, human, to prevent one-infertility and cardiotoxicity induced by chemotherapy occurring in cancer survivors.